Clinical Trial Update: The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how different RAAS blockade strategies affect proteinuria in chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Proteinuria

Drugs mentioned

• RAAS blockade (various types)

Snippet

Sponsor: Medical University of Gdansk | Conditions: Chronic Kidney Disease, Proteinuria | Phase 4 | Status: COMPLETED